The biopesticides market is projected to grow from USD 6.7 billion in 2023 to USD 13.9 billion by 2028 growing at a CAGR of 15.9% during the forecast period. Growing awareness of the harmful effects of chemical pesticides has led to a rising demand for environmentally friendly and organic pest control methods. Biopesticides, derived from natural materials like plants, bacteria, and fungi, are seen as safer and more sustainable options. Governments and regulatory bodies worldwide are implementing stricter pesticide regulations to safeguard human health and the environment, resulting in a need for alternative solutions. Biopesticides, with their lower toxicity and safer profile for humans, non-target organisms, and ecosystems, are fulfilling this demand.
The key players in the industrial enzymes market include BASF SE (Germany), Bayer AG (Germany), Syngenta AG (Switzerland), UPL (India), FMC Corporation (US), Pro Farm Group Inc. (US), Novozymes (Denmark), Isagro S.p.A (Italy), Nufarm (Australia), and Certis USA L.L.C. (US). The key strategies the leading market players adopted include new product launches, mergers, partnerships, and expansions. For instance, In December 2022, FMC Corporation, a prominent global agricultural sciences company, and Micropep Technologies (Micropep), a leader in micropeptide technology, have recently announced a strategic collaboration aimed at developing biological solutions to combat destructive herbicide-resistant weeds that negatively impact crop yields. This collaborative effort will significantly accelerate the ongoing development of natural weed control products, which are based on the utilization of short protein molecules naturally produced by plant cells. Through an exclusive multi-year agreement, the partnership will primarily concentrate on creating novel solutions for effectively managing key herbicide-resistant weeds found in corn and soybeans. By combining their respective research and development capabilities, the two companies will leverage Micropep's cutting-edge technology to expedite and enhance the process of identifying innovative biological herbicides with a higher rate of success.
To know about the assumptions considered for the study download the pdf brochure
In May 2022, UPL recently announced the acquisition of OptiCHOS by UPL Group for its Natural Plant Protection (NPP) business unit. OptiCHOS is a naturally derived fungicide that joins the portfolio of natural and biologically derived agricultural inputs and technologies within the NPP division. OptiCHOS presents farmers with a novel disease control solution that is low-risk, residue-free, and biodegradable. It offers a broad spectrum of disease control while minimizing its impact on the environment and human health. The active ingredients of OptiCHOS were developed by BioCHOS, a spin-off of the Norwegian University of Life Sciences, utilizing the chitin-rich by-products of the shellfish industry. As part of the acquisition, NPP obtains the registration data package and patents necessary for OptiCHOS, allowing its use in combination with a wide range of fungicides. This acquisition provides the agricultural industry with a diverse selection of options for effectively managing plant diseases.
BASF SE is a prominent global chemical manufacturer and marketer, operating across six major business segments: chemicals, materials, industrial solutions, surface technologies, nutrition, and care, as well as agricultural solutions. Within the agricultural solutions segment, BASF offers a comprehensive portfolio of biological solutions for crop protection, seed treatment, turf and ornamentals, and urban and rural pest control. The crop protection segment focuses on providing foliar and drench-applied biological solutions to growers, assisting in pest and disease control while managing residues and resistance. This encompasses biopesticides (fungicides and insecticides), inoculants, biostimulants, and pheromones, designed to integrate into integrated pest management (IPM) programs for both greenhouse and open field cultivation. In March 2021, BASF and AgBiome have recently entered into an agreement to introduce a new biological fungicide to the European market, as well as key countries in the Middle East and Africa. The fungicide, originally developed by AgBiome and known as Howler in the United States, offers multiple modes of action and demonstrates preventive and long-lasting efficacy against a wide range of soilborne and foliar diseases. Under this collaboration, BASF will provide support for further development and registration processes and will exclusively distribute the product in Europe, the Middle East, and Africa. The partners anticipate obtaining the necessary registrations, and initial market launches in selected countries are expected to take place in 2024/2025. This collaboration aims to address the growing demand for effective biological solutions for disease management in agricultural crops across the regions mentioned.
Bayer AG is a global life sciences company that serves the healthcare and agriculture sectors. It operates across four main business segments: pharmaceuticals, consumer health, animal health, and crop science. The crop science division focuses on developing seed and crop protection products, including biopesticides. Bayer has an extensive collection of over 125,000 microbial strains, enabling the company to leverage genetic diversity in the development of new and beneficial products. Through advanced research in microbial and RNA technology, Bayer is committed to delivering innovative solutions. RNA interference (RNAi) technology plays a crucial role in enhancing the efficiency of their products. The acquisition of Monsanto in the United States has further propelled Bayer's research in RNAi technology, resulting in significant advancements in crop protection solutions. By leveraging this technology, Bayer aims to enhance the effectiveness of its offerings for the benefit of farmers and the agricultural industry. In April 2022, Bayer AG announced its intention to enter into an agreement for Ginkgo Bioworks to acquire Bayer's West Sacramento Biologics Research & Development (R&D) site and internal discovery and lead optimization platform. This transaction is expected to be finalized by the end of 2022, subject to regulatory approvals and final negotiation of agreement terms. As part of the deal, Bayer will also gain access to Joyn Bio's nitrogen-fixing technologies, marking the successful conclusion of the joint venture between Leaps by Bayer AG and Ginkgo Bioworks established in 2017. The acquisition will establish Ginkgo Bioworks as a strategic partner for Bayer AG in the microbial field over several years. Together, they aim to develop biological solutions in areas such as nitrogen optimization, carbon sequestration, and next-generation crop protection. This collaboration signifies Bayer's commitment to advancing its capabilities in biological research and underscores its dedication to innovation and sustainability in the agriculture sector.
Biopesticides Market by Type (Bioinsecticides, Biofungicides, Bionematicides), Crop Type (Cereals & Grains, Oilseeds & Pulses), Formulation (Liquid and Dry), Source (Microbials, Biochemicals) Mode of Application, Region - Global Forecast to 2028
Mr. Aashish Mehra
630 Dundee Road
Northbrook, IL 60062
USA : 1-888-600-6441
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.SEND ME A FREE SAMPLE